EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Isoalantolactone exerts anti‐melanoma effects via inhibiting PI3K / AKT / mTOR and STAT3 signaling in cell and mouse models

Jun-Kui Li iD, Xiao-Li Jiang, Zhu Zhang, Wen-Qing Chen, Jun-Jie Peng, Bin Liu iD, Pei-Li Zhu, Ken-Kin-Lam Yung

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8132 ↗

At a glance

Journal article in Phytotherapy Research, 2024. Written by Jun-Kui Li and 7 co-authors. Institution: Department of Biology, Hong Kong Baptist University (HKBU), Hong Kong SAR, China. Major MEDLINE topics: STAT3 Transcription Factor, TOR Serine-Threonine Kinases, Signal Transduction, Proto-Oncogene Proteins c-akt. Cited 11 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Aim Although the anti‐cancer activity of isoalantolactone (IATL) has been extensively studied, the anti‐melanoma effects of IATL are still unknown. Here, we have investigated the anti‐melanoma effects and mechanism of action of IATL. MTT and crystal violet staining assays were performed to detect the inhibitory effect of IATL on melanoma cell viability. Apoptosis and cell cycle arrest induced by IATL were examined using flow cytometry. The molecular mechanism of IATL was explored by Western blotting, confocal microscope analysis, molecular docking, and cellular thermal shift assay (CETSA). A B16F10 allograft mouse model was constructed to determine the anti‐melanoma effects of IATL in vivo. The results showed that IATL exerted anti‐melanoma effects in vitro and in vivo. IATL induced cytoprotective autophagy in melanoma cells by inhibiting the PI3K/AKT/mTOR signaling. Moreover, IATL inhibited STAT3 activation both in melanoma cells and allograft tumors not only by binding to the SH2 domain of STAT3 but also by suppressing the activity of its upstream kinase Src. These findings demonstrate that IATL exerts anti‐melanoma effects via inhibiting the STAT3 and PI3K/AKT/mTOR signaling pathways, and provides a pharmacological basis for developing IATL as a novel phytotherapeutic agent for treating melanoma clinically.

Subjects

MeSH terms (MEDLINE)

STAT3 Transcription FactorTOR Serine-Threonine KinasesSignal TransductionProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMelanoma, ExperimentalAnimalsMiceCell Line, TumorApoptosisMice, Inbred C57BLHumansFuransMolecular Docking SimulationCell SurvivalMelanomaAutophagySesquiterpenes

Author keywords

PI3K/AKT/mTOR signalingSTAT3 signalingapoptosis and autophagyisoalantolactonemelanoma

Substances

STAT3 Transcription FactorTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesisoalantolactoneStat3 protein, mousemTOR protein, mouseFuransSesquiterpenes

Authors and institutions

  • Department of Biology, Hong Kong Baptist University (HKBU), Hong Kong SAR, China.
  • Golden Meditech Center for NeuroRegeneration Sciences (GMCNS), HKBU, Hong Kong SAR, China.
  • HKBU Institute of Research and Continuing Education, Shenzhen, China.
  • Department of Traditional Chinese Medicine, Institute of Integration of Traditional and Western Medicine of Guangzhou Medical University, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical…

ORCID profiles: Jun-Kui Li, Bin Liu

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Cite

APA

Li, J. K., Jiang, X. L., Zhang, Z., Chen, W. Q., Peng, J. J., Liu, B., Zhu, P. L., & Yung, K. K. (2024). Isoalantolactone exerts anti‐melanoma effects via inhibiting PI3K / AKT / mTOR and STAT3 signaling in cell and mouse models. Phytotherapy Research. https://doi.org/10.1002/ptr.8132

Vancouver

Li JK, Jiang XL, Zhang Z, Chen WQ, Peng JJ, Liu B, et al. Isoalantolactone exerts anti‐melanoma effects via inhibiting PI3K / AKT / mTOR and STAT3 signaling in cell and mouse models. Phytotherapy Research. 2024. doi:10.1002/ptr.8132

BibTeX
@article{Li2024,
  author = {Li, Jun-Kui and Jiang, Xiao-Li and Zhang, Zhu and Chen, Wen-Qing and Peng, Jun-Jie and Liu, Bin and Zhu, Pei-Li and Yung, Ken-Kin-Lam},
  title = {Isoalantolactone exerts anti‐melanoma effects via inhibiting PI3K / AKT / mTOR and STAT3 signaling in cell and mouse models},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8132}
}
Start for free →